FDA Hits Aesica Over Quality Controls, Record-Keeping Post author:Sam Post published:April 19, 2017 Post category:Drug Industry Daily The FDA has cited contract manufacturer Aesica for quality and record-keeping problems. Source: Drug Industry Daily You Might Also Like AstraZeneca Agrees to $110 Million Settlement in Texas Medical Fraud Cases August 8, 2018 FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products June 13, 2018 Supplement Company Draws Warning Over GMPs May 25, 2017